2,078
Views
1
CrossRef citations to date
0
Altmetric
Research Articles

Chronic pain, prescribed opioids and overdose risk: a qualitative exploration of the views of affected individuals and family members

, , , , &
Pages 229-240 | Received 15 Sep 2021, Accepted 17 Dec 2021, Published online: 17 Jan 2022

References

  • Achkar, M. A., Revere, D., Dennis, B., Mackie, P., Gupta, S., & Grannis, S. (2017). Exploring perceptions and experiences of patients who have chronic pain as state prescription opioid policies change: A qualitative study in Indiana. British Medical Journal Open, 7(11), 1–9. https://doi.org/10.1136/bmjopen-2016-015083
  • Antoniou, T., Ala-Leppilampi, K., Shearer, D., Parsons, J. A., Tadrous, M., & Gomes, T. (2019). Like being put on an ice floe and shoved away: A qualitative study of the impacts of opioid-related policy changes on people who take opioids. The International Journal on Drug Policy, 66, 15–22. https://doi.org/10.1016/j.drugpo.2019.01.015
  • Alvin, M., Picco, L., Wood, P., Mnatzaganian, G., & Nielsen, S. (2020). Community pharmacists’ preparedness to intervene with concerns around prescription opioids: findings from a nationally representative survey. International Journal of Clinical Pharmacy, 1, 3. https://doi.org/10.1007/s11096-020-01152-8
  • Arman, M., Gebhardt, A., Hök Nordberg, J., & Andermo, S. (2020). Women’s lived experiences of chronic pain: Faces of gendered suffering. Qualitative Health Research, 30(5), 772–782. https://doi.org/10.1177/1049732319888478
  • Bagley, S. M., Peterson, J., Cheng, D. M., Jose, C., Quinn, E., O’Connor, P. G., & Walley, A. Y. (2015). Overdose education and naloxone rescue kits for family members of individuals who use opioids: Characteristics, motivations, and naloxone use. Substance Abuse, 36(2), 149–154. https://doi.org/10.1080/08897077.2014.989352
  • Bagley, S. M., Forman, L. S., Ruiz, S., Cranston, K., & Walley, A. Y. (2018). Expanding access to naloxone for family members: The Massachusetts experience. Drug and Alcohol Review, 37(4), 480–486. 2017; https://doi.org/10.1111/dar.12551
  • Bahji, A. (2020). Commentary on Hayes et al. (2020): The harms of opioid dose escalation in the management of chronic non-cancer pain. Addiction, 115(6), 1113–1114. https://doi.org/10.1111/add.14965
  • Bailey, J., Nafees, S., Jones, L., & Poole, R. (2021). Rationalisation of long-term high-dose opioids for chronic pain: Development of an intervention and conceptual framework. British Journal of Pain, 15(3), 326–334. https://doi.org/10.1177/2049463720958731
  • Baker, K. S., Gibson, S., Georgiou-Karistianis, N., Roth, R. M., & Giummarra, M. J. (2016). Everyday executive functioning in chronic Pain: Specific deficits in working memory and emotion control, predicted by mood, medications, and pain interference. The Clinical Journal of Pain, 32(8), 673–680. https://doi.org/10.1097/AJP.0000000000000313
  • Baker, K. S., Gibson, S., Georgiou-Karistianis, N., Roth, R. M., Giummarra, M. J., Jamison, R. N., & Nielsen, S. (2020). Take-home naloxone – Topic overview |. Pain Medicine, 32(1), 3. www.emcdda.europa.eu. https://doi.org/10.1007/s00213-018-5060-z
  • Ballantyne, J. C., Kalso, E., & Stannard, C. (2016). WHO analgesic ladder: A good concept gone astray. BMJ, 352, i20. https://doi.org/10.1136/bmj.i20
  • Bennett, A. S., Freeman, R., Des Jarlais, D. C., & Aronson, I. D. (2020). Reasons people who use opioids do not accept or carry no-cost naloxone: Qualitative interview study. JMIR Formative Research, 4(12), e22411. https://doi.org/10.2196/22411
  • Benyamin, R., Trescot, A., Datta, S., Buenaventura, R., Adlaka, R., Sehgal, N., Glaser, E. E., & Vallejo, R. (2008). Opioid Complications and Side Effects. Pain Physician, 11(2 Suppl), S105–S20. PMID: 18443635.
  • Binswanger, I. A., Koester, S., Mueller, S. R., Gardner, E. M., Goddard, K., & Glanz, J. M. (2015). Overdose education and naloxone for patients prescribed opioids in primary care: a qualitative study of primary care staff. Journal of General Internal Medicine, 30(12), 1837–1844. https://doi.org/10.1007/s11606-015-3394-3
  • Blake, S., Ruel, B., Seamark, C., & Seamark, D. (2007). Experiences of patients requiring strong opioid drugs for chronic non-cancer pain: A patient-initiated study. British Journal of General Practice, 57(535), 101–109. PMID: 17263926.
  • Bowles, J. M., & Lankenau, S. E. (2019). I gotta go with modern technology, So I’m Gonna Give 'em the Narcan: The diffusion of innovations and an opioid overdose prevention program. Qualitative Health Research, 29(3), 345–356. https://doi.org/10.1177/1049732318800289
  • Brooks, E. A., Unruh, A., & Lynch, M. E. (2015). Exploring the lived experience of adults using prescription opioids to manage chronic noncancer pain. Pain Research & Management, 20(1), 15–22. https://doi.org/10.1155/2015/314184
  • Buchman, D. Z., Ho, A., & Illes, J. (2016). You present like a drug addict: Patient and clinician perspectives on trust and trustworthiness in chronic pain management. Pain Medicine, ), 17(8), 1394–1406. https://doi.org/10.1093/pm/pnv083
  • Burton, G., McAuley, A., Schofield, J., Yeung, A., Matheson, C., & Parkes, T. (2021). A systematic review and meta-analysis of the prevalence of take-home naloxone (THN) ownership and carriage. The International Journal on Drug Policy, 96, 103298. https://doi.org/10.1016/j.drugpo.2021.103298
  • Campbell, G., Nielsen, S., Bruno, R., Lintzeris, N., Cohen, M., Hall, W., Larance, B., Mattick, R. P., & Degenhardt, L. (2015). The pain and opioids in treatment study: characteristics of a cohort using opioids to manage chronic non-cancer pain. Pain, 156(2), 231–242. https://doi.org/10.1097/01.j.pain.0000460303.63948.8e
  • Cohen, S., Vase, L., & Hooten, W. M. (2021). Chronic pain: an update on burden, best practices and new advances. Lancet, 397(10289), 2082–2097. https://doi.org/10.1016/S0140-6736(21)00393-7
  • Conroy, S., C., & Bjork, J. M. (2018). Death ambivalence and treatment seeking: suicidality in opiate addiction. Current Treatment Options in Psychiatry, 5(3), 291–300. https://doi.org/10.1007/s40501-018-0152-2
  • Dassieu, L., Heino, A., Develay, É., Kaboré, J., Pagé, G., Moor, G., Hudspith, M., & Choinière, M. (2021a). Conversations about opioids: impact of the opioid overdose epidemic on social interactions for people who live with chronic pain. Qualitative Health Research, 31(9), 1657–1669. https://doi.org/10.1177/10497323211003063
  • Dassieu, L., Heino, A., Develay, É., Kaboré, J., Pagé, G., Moor, G., Hudspith, M., & Choinière, M. (2021b). They think you’re trying to get the drug: Qualitative investigation of chronic pain patients' health care experiences during the opioid overdose epidemic in Canada. Canadian Journal of Pain = Revue Canadienne de la Douleur, 5(1), 66–80. https://doi.org/10.1080/24740527.2021.1881886
  • Degenhardt, L., Grebely, J., Stone, J., Hickman, M., Vickerman, P., Marshall, B. D. L., Bruneau, J., Altice, F. L., Henderson, G., Rahimi-Movaghar, A., & Larney, S. (2019). Global patterns of opioid use and dependence: Harms to populations, interventions, and future action. The Lancet, 394(10208), 1560–1579. https://doi.org/10.1016/S0140-6736(19)32229-9
  • De Sola, H., Maquibar, A., Failde, I., Salazar, A., & Goicolea, I. (2020). Living with opioids: A qualitative study with patients with chronic low back pain. Health Expectations, 23(5), 1118–1128. https://doi.org/10.1111/hex.13089
  • Dowell, D., Haegerich, T. M., & Chou, R. (2016). CDC guideline for prescribing opioids for chronic pain-United States, 2016. JAMA Network, 315(15), 1624–1645. https://doi.org/10.1001/jama.2016.1464
  • Faculty of Pain Medicine. (2021). Side effects of opioids. Retrieved 6 September 2021 from https://www.fpm.ac.uk/opioids-aware-clinical-use-opioids/side-effects-opioids
  • Fomiatti, R., Farrugia, A., Fraser, S., Dwyer, R., Neale, J., & Strang, J. (2020). Addiction stigma and the production of impediments to take-home naloxone uptake. Health: An Interdisciplinary Journal for the Social Study of Health, Illness and Medicine, 2020, 136345932092586. https://doi.org/10.1177/1363459320925863
  • Gale, N. K., Heath, G., Cameron, E., Rashid, S., & Redwood, S. (2013). Using the framework method for the analysis of qualitative data in multi-disciplinary health research. BMC Medical Research Methodology, 13(117), 117. https://doi.org/10.1186/1471-2288-13-117
  • Gregorian, R. S., Gasik, A., Kwong, W. J., Voeller, S., & Kavanagh, S. (2010). Importance of side effects in opioid treatment: A trade-off analysis with patients and physicians. The Journal of Pain, 11(11), 1095–1108. https://doi.org/10.1016/j.jpain.2010.02.007
  • Hayes, H., Buckland, S., & Tarpey, M. (2012). Briefing notes for researchers: Public involvement in NHS, public health and social care research. Retrieved 6 September 2021 from https://www.invo.org.uk/wp-content/uploads/2014/11/9938_INVOLVE_Briefing_Notes_WEB.pdf
  • Heavey, S. C., Chang, Y. P., Vest, B. M., Collins, R. L., Wieczorek, W., & Homish, G. G. (2018). 'I have it just in case' – Naloxone access and changes in opioid use behaviours. The International Journal on Drug Policy, 51, 27–35. https://doi.org/10.1016/j.drugpo.2017.09.015
  • Higgins, C., Smith, B. H., & Matthews, K. (2018). Substance misuse in patients who have comorbid chronic pain in a clinical population receiving methadone maintenance therapy for the treatment of opioid dependence. Drug and Alcohol Dependence, 193, 131–136. https://doi.org/10.1016/j.drugalcdep.2018.08.038
  • Higgins, C., Smith, B. H., & Matthews, K. (2020). Comparison of psychiatric comorbidity in treatment-seeking, opioid-dependent patients with versus without chronic pain. Addiction, 115(2), 249–258. https://doi.org/10.1111/add.14768
  • Higgins, C., Smith, B. H., & Matthews, K. (2021). Opioid dependence disorder and comorbid chronic pain: comparison of groups based on patient-attributed direction of the causal relationship between the two conditions. British Journal of Pain, 2021, 1–12. https://doi.org/10.1177/20494637211026339
  • Holloway, I., Sofaer-Bennett, B., & Walker, J. (2007). The stigmatisation of people with chronic back pain. Disability and Rehabilitation, 29(18), 1456–1464. https://doi.org/10.1080/09638280601107260
  • Jamison, R. N., & Virts, K. L. (1990). The influence of family support on chronic pain. Behaviour Research and Therapy, 28(4), 283–287. https://doi.org/10.1016/0005-7967(90)90079-X
  • Jani, M., Yimer, B. B., Sheppard, T., Lunt, M., & Dixon, W. G. (2020). Time trends and prescribing patterns of opioid drugs in UK primary care patients with non-cancer pain: A retrospective cohort study. PLOS Medicine, 17(10), e1003270–16. https://doi.org/10.1371/journal.pmed.1003270
  • Karos, K., McParland, J. L., Bunzli, S., Devan, H., Hirsh, A., Kapos, F. P., Keogh, E., Moore, D., Tracy, L., & Ashton-James, C. E. (2020). The social threats of COVID-19 for people with chronic pain. Pain, 161(10), 2229–2235. https://doi.org/10.1097/j.pain.0000000000002004
  • Keane, H. (2013). Categorising methadone: Addiction and analgesia. The International Journal on Drug Policy, 24(6), e18–e24. https://doi.org/10.1016/j.drugpo.2013.05.007
  • Lagisetty, P. A., Healy, N., Garpestad, C., Jannausch, M., Tipirneni, R., & Bohnert, A. S. B. (2019). Access to primary care clinics for patients with chronic pain receiving opioids. JAMA Network Open, 2 (7), e196928. https://doi.org/10.1001/jamanetworkopen.2019.6928
  • Lai, J. T., Goldfine, C. E., Chapman, B. P., Taylor, M. M., Rosen, R. K., Carreiro, S. P., & Babu, K. M. (2021). Nobody wants to Be Narcan’d: A pilot qualitative analysis of drug users’ perspectives on naloxone. The Western Journal of Emergency Medicine, 22(2), 339–345. https://doi.org/10.5811/westjem.2020.10.48768
  • Larance, B., Degenhardt, L., Lintzeris, N., Winstock, A., & Mattick, R. (2011). Definitions related to the use of pharmaceutical opioids: Extramedical use, diversion, non-adherence and aberrant medication-related behaviours. Drug and Alcohol Review, 30(3), 236–245. https://doi.org/10.1111/j.1465-3362.2010.00283.x
  • Ljungvall, H., Rhodin, A., Wagner, S., Zetterberg, H., & Åsenlöf, P. (2020). My life is under control with these medications: An interpretative phenomenological analysis of managing chronic pain with opioids. BMC Musculoskeletal Disorders, 21(1), 1–14. https://doi.org/10.1186/s12891-020-3055-5
  • Mathieson, S., Wertheimer, G., Maher, C. G., Christine Lin, C.-W., McLachlan, A. J., Buchbinder, R., Pearson, S.-A., & Underwood, M. (2020). What proportion of patients with chronic noncancer pain are prescribed an opioid medicine? Systematic review and meta-regression of observational studies. Journal of Internal Medicine, 287(5), 458–474. https://doi.org/10.1111/joim.13026
  • McAuley, A., & Bird, S. M. (2019). Take-home naloxone is a global issue, in practice and in research: A response to Heavey et al. The International Journal on Drug Policy, 63 (August 2018), 111–112. https://doi.org/10.1016/j.drugpo.2018.08.003
  • McAuley, A., Munro, A., Bird, S. M., Hutchinson, S. J., Goldberg, D. J., & Taylor, A. (2016). Engagement in a National Naloxone Programme among people who inject drugs. Drug and Alcohol Dependence, 162, 236–240. https://doi.org/10.1016/j.drugalcdep.2016.02.031
  • McAuley, A., Munro, A., & Taylor, A. (2018). Once I’d done it once it was like writing your name: Lived experience of take-home naloxone administration by people who inject drugs. The International Journal on Drug Policy, 58(May), 46–54. https://doi.org/10.1016/j.drugpo.2018.05.002
  • McDonald, R., Campbell, N. D., & Strang, J. (2017). Twenty years of take-home naloxone for the prevention of overdose deaths from heroin and other opioids-Conception and maturation. Drug and Alcohol Dependence, 178, 176–187. https://doi.org/10.1016/j.drugalcdep.2017.05.001
  • Meadowcroft, D., & Whitacre, B. (2021). Do prescription drug monitoring programs encourage prescription – or illicit – opioid abuse? Substance Abuse, 42(1), 65–75. https://doi.org/10.1080/08897077.2019.1695707
  • Medicines and Healthcare products Regulatory Agency (HRA). (2020). Opioids: risk of dependence and addiction. Retrieved February 10, 2021, from https://www.gov.uk/drug-safety-update/opioids-risk-of-dependence-and-addiction
  • Mills, S. E. E., Nicolson, K. P., & Smith, B. H. (2019). Chronic pain: a review of its epidemiology and associated factors in population-based studies. British Journal of Anaesthesia, 123(2), e273–e283. https://doi.org/10.1016/j.bja.2019.03.023
  • Moore, A. J., Richardson, J. C., Sim, J., Bernard, M., & Jordan, K. P. (2014). Older people’s perceptions of remaining physically active and living with chronic pain. Qualitative Health Research, 24(6), 761–772. https://doi.org/10.1177/1049732314529663
  • Mueller, S. R., Koester, S., Glanz, J. M., Gardner, E. M., & Binswanger, I. A. (2017). Attitudes toward naloxone prescribing in clinical settings: A qualitative study of patients prescribed high dose opioids for chronic non-cancer pain. Journal of General Internal Medicine, 32(3), 277–283. https://doi.org/10.1007/s11606-016-3895-8
  • Mueller, S. R., Walley, A. Y., Calcaterra, S. L., Glanz, J. M., & Binswanger, I. A. (2015). A review of opioid overdose prevention and naloxone prescribing: Implications for translating community programming into clinical practice. Substance Abuse, 36(2), 240–253. https://doi.org/10.1080/08897077.2015.1010032
  • National Institute for Health and Care Excellence. (2020). British National Formulary. Retrieved 6 September 2021 from https://bnf.nice.org.uk/
  • National Records of Scotland. (2021). Drug-related deaths in Scotland in 2020. National Statistics. Retrieved 6 September 2021 from https://www.nrscotland.gov.uk/statistics-and-data/statistics/statistics-by-theme/vital-events/deaths/drug-related-deaths-in-scotland/2020
  • Neale, J., & Strang, J. (2015). Naloxone-does over-antagonism matter? Evidence of iatrogenic harm after emergency treatment of heroin/opioid overdose. Addiction (Abingdon, England), 110(10), 1644–1652. https://doi.org/10.1111/add.13027
  • Neuman, M. D., Bateman, B. T., & Wunsch, H. (2019). Inappropriate opioid prescription after surgery. The Lancet, 393(10180), 1547–1557. https://doi.org/10.1016/S0140-6736(19)30428-3
  • Nicolaidis, C. (2011). Police officer, deal-maker, or health care provider? Moving to a patient-centered framework for chronic opioid management. Pain Medicine, 12(6), 890–897. https://doi.org/10.1111/j.1526-4637.2011.01117.x
  • Nielsen, S., Peacock, A., Lintzeris, N., Bruno, R., Larance, B., & Degenhardt, L. (2018). Knowledge of opioid overdose and attitudes to supply of take-home naloxone among people with chronic noncancer pain prescribed opioids. Pain Medicine, 19(3), 533–540. https://doi.org/10.1093/pm/pnx021
  • Payne, B., & Norfleet, M. A. (1986). Chronic pain and the family: A review. Pain, 26(1), 1–22. https://doi.org/10.1016/0304-3959(86)90169-7
  • Peacock, A., Degenhardt, L., Mcrim, G., Campbell, G., Larance, B., Nielsen, S., Hall, W., Mattick, R. P., & Bruno, R. (2016). A typology of predictive risk factors for non-adherent medication-related behaviors among chronic non-cancer pain patients prescribed opioids: a cohort study. Pain Physician, 19(3), E421-34. PMID: 27008298.
  • Ritchie, J., Nicholls, C. M., Ormston, R., & Lewis, J. (2013). Qualitative research practice: A guide for social science students and researchers. SAGE.
  • Rogers, A. H., Bakhshaie, J., Orr, M. F., Ditre, J. W., & Zvolensky, M. J. (2020). Health literacy, opioid misuse, and pain experience among adults with chronic pain. Pain Medicine, 21(4), 670–676. https://doi.org/10.1093/pm/pnz062
  • Scherrer, J. F., Salas, J., Sullivan, M. D., Ahmedani, B. K., Copeland, L. A., Bucholz, K. K., Burroughs, T., Schneider, F. D., & Lustman, P. J. (2018). Impact of adherence to antidepressants on long-term prescription opioid use cessation. The British Journal of Psychiatry, 212(2), 103–111. https://doi.org/10.1192/bjp.2017.25
  • Schofield, J., Steven, D., Foster, R., Matheson, C., Baldacchino, A., McAuley, A., & Parkes, T. (2021). Quantifying prescribed high dose opioids in the community and risk of overdose. BMC Public Health, 21, 1174. https://doi.org/10.1186/s12889-021-11162-4
  • Scottish Intercollegiate Guidelines Network. (2019). SIGN 136, Management of Chronic Pain: A national clinical guideline (Vol. 2020). Retrieved 6 September 2021 from https://www.sign.ac.uk/media/1108/sign136_2019.pdf
  • Slat, S., Yaganti, A., Thomas, J., Helminski, D., Heisler, M., Bohnert, A., & Lagisetty, P. (2021). Opioid policy and chronic pain treatment access experiences: A multi-stakeholder qualitative analysis and conceptual model. Journal of Pain Research, 14, 1161–1169. https://doi.org/10.2147/JPR.S282228
  • Slade, S. C., Molloy, E., & Keating, J. L. (2009). Stigma experienced by people with nonspecific chronic low back pain: A qualitative study. Pain Medicine, 10(1), 143–154. https://doi.org/10.1111/j.1526-4637.2008.00540.x
  • Smith, B., Mair, A., & Calderwood, C. (2018). Quality prescribing for chronic pain: A guide for improvement. NHS Scotland. Retrieved 6 September 2021 from https://www.therapeutics.scot.nhs.uk/wp-content/uploads/2018/03/Strategy-Chronic-Pain-Quality-Prescribing-for-Chronic-Pain-2018.pdf
  • Snelling, J. (1994). The effect of chronic pain on the family unit. Journal of Advanced Nursing, 19(3), 543–551. https://doi.org/10.1111/j.1365-2648.1994.tb01119.x
  • Sullivan, M. D., Korff, M. V., Banta-Green, C., Merrill, J. O., & Saunders, K. (2010). Problems and concerns of patients receiving chronic opioid therapy for chronic non-cancer pain. Pain, 149(2), 345–353. https://doi.org/10.1016/j.pain.2010.02.037
  • Toye, F., Seers, K., Allcock, N., Briggs, M., Carr, E., Andrews, J. A., & Barker, K. (2013). Patients’ experiences of chronic non-malignant musculoskeletal pain: A qualitative systematic review. British Journal of General Practice, 63(617), e829–e841. https://doi.org/10.3399/bjgp13X675412
  • Toye, F., Seers, K., Hannink, E., & Barker, K. (2017). A mega-ethnography of eleven qualitative evidence syntheses exploring the experience of living with chronic non-malignant pain. BMC Medical Research Methodology, 17(1), 1–11. https://doi.org/10.1186/s12874-017-0392-7
  • Upshur, C. C., Bacigalupe, G., & Luckmann, R. (2010). They don’t want anything to do with you: Patient views of primary care management of chronic pain. Pain Medicine, 11(12), 1791–1798. https://doi.org/10.1111/j.1526-4637.2010.00960.x
  • Vallerand, A., & Nowak, L. A. (2009). Chronic opioid therapy for nonmalignant pain: the patient’s perspective. Part I-life before and after opioid therapy. Pain Management Nursing, 10(3), 165–172. https://doi.org/10.1016/j.pmn.2009.03.007
  • Voon, P., Greer, A. M., Amlani, A., Newman, C., Burmeister, C., & Buxton, J. A. (2018). Pain as a risk factor for substance use: a qualitative study of people who use drugs in British Columbia, Canada. Harm Reduction Journal, 15(1), 35. https://doi.org/10.1186/s12954-018-0241-y
  • Webster, F., Rice, K., & Sud, A. (2020). A critical content analyis of media reporting on opioids: The social construction of an epidemic. Social Science & Medicine, 244, 112642. https://doi.org/10.1016/j.socscimed.2019.112642
  • West, C., Usher, K., Foster, K., & Stewart, L. (2012). Chronic pain and the family: The experience of the partners of people living with chronic pain. Journal of Clinical Nursing, 21(23–24), 3352–3360. https://doi.org/10.1111/j.1365-2702.2012.04215.x
  • Wilson, J., Lam, T., Scott, D., Crossin, R., Matthews, S., Smith, K., Lubman, D., & Nielsen, S. (2020). 'Extreme personal stress' and 'a lot of pain': Exploring the physical, mental and social contexts of extramedical pharmaceutical opioid use in Australian paramedic case descriptions. Drug and Alcohol Review, 39(7), 870–878. https://doi.org/10.1111/dar.13118